Standard BioTools Stockholders Approve Merger and Mass Cytometry Business Sale Proposals
Standard BioTools stockholders approved all proposals related to its merger with Treeline Biosciences and the sale of its mass cytometry business.
Standard BioTools stockholders approved all proposals related to its merger with Treeline Biosciences and the sale of its mass cytometry business.